Brittany Weber
@Bweber04
Followers
2K
Following
4K
Media
25
Statuses
437
Cardiologist @BrighamWomens I Director, BWH Cardio-Rheumatology Clinic I CV imaging @BWHCVImaging |Former BWH CMR @BrighamChiefs | Alum Penn MSTP
Boston, MA
Joined April 2013
RT @RonBlankstein: End of another academic year. So fortunate to train, work with, and learn from the best of the best in CV imaging @BWH….
0
16
0
RT @lupus_hub: CONGRESS | #EULAR2025| POSTER.Brittany Weber, @Bweber04, @BrighamWomens, shares findings of a post-hoc analysis from the PAI….
0
2
0
A wonderful evening w so many celebrations but most importantly @RonBlankstein on his mentorship to all and his well deserved 2025 SCCT Agatston Award!! Thank you Ron for all that you do!! #prevention #imaging 💪🙌❤️🌟.
Grateful for a special evening with the CV Prevention and Imaging Lab! Honored to be part of such a brilliant team and deeply thankful for the leadership and mentorship of @RonBlankstein — Congratulations on your well-deserved 2025 Agatston Award! 🫀👏🎉
0
7
49
RT @EMEUNET: New Episode!. Join @rudi_shukla and @Pierre-Antoine Juge joined by @Bweber04 in the latest #EMEUNETPodcast as they shine a li….
0
4
0
RT @ACCinTouch: At #ACC25, four pioneering cardiovascular researchers were recognized with ACC Distinguished Awards for their groundbreakin….
0
9
0
RT @DrMarthaGulati: @Bweber04 @SmidtHeart .♥️ NLRP3 inflammasome role in CVD is important.♥️hsCRP is a down stream market of inflammation,….
0
2
0
RT @DrMarthaGulati: CCTA in asymptomatic individuals can help identify .♥️amount of plaque.♥️ plaque volume.♥️ inflammation.♥️stenosis seve….
0
8
0
RT @NYUCVDPrevent: 📢 New Publication. This review highlights #psoriasis as an independent risk factor for #cardiovascular disease. A coordi….
0
3
0
Thrilled to be a part of this study led by superstar 🌟@AndreZimerman in @CircAHA 👇! FOURIER analysis, PCSK9i in systemic inflammatory diseases (RA most common AID), and check out @AndreZimerman 🔥thread summarizing key points of the study. @rgiugliano @alkunzler.
Intensive LDL-C lowering with Evolocumab may lead to greater relative reduction in cardiovascular events in patients with autoimmune or inflammatory diseases. @AndreZimerman @bweber04 @analaurakunzler.@rgiuglaino
0
5
50
RT @AndreZimerman: Does the CV benefit of evolocumab differ in patients with autoimmune or inflammatory diseases?. The answer lies at the i….
0
13
0
RT @NYUCVDPrevent: 🫀 Register for the 5th Annual #CardioRheum Symposium & get FREE access to Medscape’s 1-hr mini-symposium:. “Race Agains….
0
2
0
RT @NYUCVDPrevent: With special thanks to @NYSCACC @theCT_ACC and @PPACMANgroup for their endorsement of this annual #CardioRheumatology c….
0
2
0
RT @BrunoLimaMDPhD: I can’t think of someone more deserving of this award then Ron Blankstein. Lifetime mentor of us all. #YesCCT
https://t….
0
14
0
RT @HDiGregorioMD: ‼️JUST PUBLISHED‼️. Patients with Rheumatologic Diseases and ASCVD are less likely to receive appropriate secondary prev….
0
5
0
We are so thrilled for this exciting🔥🔥 spotlight below! Check out @JAHA_AHA spotlight on cardiorheum! Deadline Aug 1st. So excited to work with the brilliant ⭐️@MMukherjeeMD!.
1
8
31
RT @ASPCardio: What a fantastic session this morning! 🎉 Huge thanks to all of our incredible speakers at ASPC’s Imaging MasterClass — you m….
0
3
0
RT @purviparwani: @Bweber04 gets the young scientist award at #ACC25!! . Congratulations Brittany! . This is testament to your hardwork and….
0
6
0
RT @ASPCardio: 🩺✨ Don't Miss ASPC’s Imaging MasterClass!.📅 Saturday, April 5 | 10 AM EDT.✅ Free Half-Day Virtual Event.🔍 Multimodality Card….
0
13
0
Thank you so much @ACCinTouch ! This is all due to all my amazing mentors 🙏and colleagues! ❤️I am excited for all the work ahead! @mdicarli @RonBlankstein @kat_liao @JosephMerolaMD @MMukherjeeMD @OMRF @IGGPenn #JoelKatz @BWHCVImaging @AbbateAntonio @garshick.
23
14
129